69 related articles for article (PubMed ID: 3596041)
1. Prediction of survival by degree of reactivity to BCG in patients with metastatic breast cancer.
Hortobagyi GN; Buzdar AU; Blumenschein GR; Yap HY; Hersh EM
Dev Biol Stand; 1986; 58 ( Pt A)():357-63. PubMed ID: 3596041
[No Abstract] [Full Text] [Related]
2. Attempt with immunotherapy to control metastatic skin nodules from breast cancer by B.C.G.
Garas J; Besbeas S; Papamatheakis J; Gropas G; Maragoudakis S; Katsenis A; Kiparissiadis P; Konstadakos P; Georgaka A
Panminerva Med; 1975; 17(5-6):193-5. PubMed ID: 1161319
[No Abstract] [Full Text] [Related]
3. [Adjuvant BCG immunotherapy for breast cancer (T1N0M0, T2N0M0)].
Sakurai T; Okada K; Yokoi H; Maebeya S; Juri M; Takimoto M; Nishimura O; Okada N
Gan To Kagaku Ryoho; 1984 Sep; 11(9):1838-42. PubMed ID: 6476845
[TBL] [Abstract][Full Text] [Related]
4. Trends in the prognosis of patients with primary metastatic breast cancer diagnosed between 1975 and 2002.
Ernst MF; van de Poll-Franse LV; Roukema JA; Coebergh JW; van Gestel CM; Vreugdenhil G; Louwman MJ; Voogd AC
Breast; 2007 Aug; 16(4):344-51. PubMed ID: 17303426
[TBL] [Abstract][Full Text] [Related]
5. Positive therapeutic response to BCG or to its soluble fraction F70 in some patients with carcinoma of the skin, of the breast or of the larynx.
Hadźiev S; Kavaklieva-Dimitrova J; Mandulova P
J Hyg Epidemiol Microbiol Immunol; 1976; 20(1):43-8. PubMed ID: 944214
[No Abstract] [Full Text] [Related]
6. [Disseminated breast carcinoma. Study of activity of immunotherapy with BCG and duration of the phase of intensive chemotherapy. Results of a randomized trial (author's transl)].
Pouillart P; Palangie T; Jouve M; Garcia-Giralt E; Magdelenat H; Asselain B
Bull Cancer; 1981; 68(1):6-18. PubMed ID: 7013868
[TBL] [Abstract][Full Text] [Related]
7. Antiestrogen-cytotoxic chemotherapy and bacillus Calmette-Guerin vaccination in stage II breast cancer: seventy-two-month follow-up.
Hubay CA; Gordon NH; Crowe JP; Guyton SP; Pearson OH; Marshall JS; Mansour EG; Hermann RE; Jones JC; Flynn WJ
Surgery; 1984 Jul; 96(1):61-72. PubMed ID: 6740497
[TBL] [Abstract][Full Text] [Related]
8. Prolonged survival associated with early lymphocyte recovery after autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer.
Porrata LF; Ingle JN; Litzow MR; Geyer S; Markovic SN
Bone Marrow Transplant; 2001 Nov; 28(9):865-71. PubMed ID: 11781647
[TBL] [Abstract][Full Text] [Related]
9. Nonspecific and selective stimulation of the immune system in the treatment of carcinoma in humans.
Falk RE; Makowka L; Ambus U; Falk JA; Bugala R; Landi S
Can Med Assoc J; 1983 Jun; 128(12):1385-8, 1422. PubMed ID: 6850464
[TBL] [Abstract][Full Text] [Related]
10. [Present state of the multidisciplinary treatment of locoregionally advanced breast cancer].
Izuo M; Iino Y
Gan No Rinsho; 1985 Jul; 31(9 Suppl):1153-9. PubMed ID: 3840541
[TBL] [Abstract][Full Text] [Related]
11. [Immunotherapy and multiple chemotherapy in primary inflammatory breast cancer: clinical study of fifteen cases ].
Ravina JH; Salat J; Letessier A; Ayral X; Madelenat P; Zylberberg B
Chirurgie; 1982; 108(1):32-6. PubMed ID: 7117011
[No Abstract] [Full Text] [Related]
12. Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor.
Huguet J; Crego M; Sabaté S; Salvador J; Palou J; Villavicencio H
Eur Urol; 2005 Jul; 48(1):53-9; discussion 59. PubMed ID: 15967252
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of long-term (5-year) survival in patients with metastatic breast cancer to the liver].
Kan N
Gan To Kagaku Ryoho; 2006 Nov; 33(12):1780-4. PubMed ID: 17212106
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer metastasis-associated genes: prognostic significance and therapeutic implications.
Moustafa AS; Nicolson GL
Oncol Res; 1997; 9(10):505-25. PubMed ID: 9507529
[TBL] [Abstract][Full Text] [Related]
15. Initially metastatic breast carcinoma has a distinct disease pattern but an equivalent outcome compared with recurrent metastatic breast carcinoma.
Jimeno A; Amador ML; González-Cortijo L; Tornamira MV; Ropero S; Valentín V; Hornedo J; Cortés-Funes H; Colomer R
Cancer; 2004 May; 100(9):1833-42. PubMed ID: 15112263
[TBL] [Abstract][Full Text] [Related]
16. [T1 G3 bladder tumors: the respective role of BCG and cystectomy].
Pfister C; Landé P; Hervé JM; Barré P; Barbagelatta M; Camey M; Botto H
Prog Urol; 1995 Apr; 5(2):231-7. PubMed ID: 7719369
[TBL] [Abstract][Full Text] [Related]
17. [Inflammatory breast carcinoma treated with a combination of chemotherapy and radiation therapy. Results of a randomized trial studying the therapeutic role of an immunotherapy with BCG (author's transl)].
Pouillart P; Palangie T; Jouve M; Garcia-Giralt E; Vilcoq JR; Bataini JP; Calle R; Fenton J; Mathieu G; Rousseau J; Asselain B
Bull Cancer; 1981; 68(2):171-86. PubMed ID: 7016224
[TBL] [Abstract][Full Text] [Related]
18. Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination.
Yu H; Levesque MA; Clark GM; Diamandis EP
Br J Cancer; 1999 Oct; 81(3):490-5. PubMed ID: 10507775
[TBL] [Abstract][Full Text] [Related]
19. The predictive value of purified protein derivative results on complications and prognosis in patients with bladder cancer treated with bacillus Calmette-Guerin.
Bilen CY; Inci K; Erkan I; Ozen H
J Urol; 2003 May; 169(5):1702-5. PubMed ID: 12686812
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic factors of metastatic breast cancer--2].
Brockmann B; Reitzig P; Dietzmann A; Cyganiak P
Z Arztl Fortbild (Jena); 1994 Apr; 88(4):305-9. PubMed ID: 8053233
[No Abstract] [Full Text] [Related]
[Next] [New Search]
